4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-15-050757
Vice Pres., Treasurer, & CAO sold 57,500 shares at an average $9.65 ($555,083)
- Vice Pres., Treasurer, & CAO acquired 30,834 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | −26,666 | $9.60 | $255,994 | 0 | D |
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Option exercise | +3,334 | $0.80 | $2,667 | 3,334 | D |
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | −3,334 | $9.70 | $32,340 | 0 | D |
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Option exercise | +27,500 | $2.30 | $63,250 | 27,500 | D |
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Sale | −27,500 | $9.70 | $266,750 | 0 | D |
| Derivatives | |||||||
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Option exercise · Stock Option (right to buy) | −3,334 | 0 | D | ||
| Lafond Kevin G Vice Pres., Treasurer, & CAO | 2015-06-03 | Option exercise · Stock Option (right to buy) | −27,500 | 55,000 | D | ||
| Open-market sales · 57,500 sh · avg $9.65 · $555,083 | |||||||
Loading xslF345X03/doc4.xml…